Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. (MDP.TO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mdp.to · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Medexus Pharmaceuticals Inc. (MDP.TO) measures how much investors pay for each dollar of the company's trailing earnings. MDP.TO's current PE ratio of N/A is calculated by dividing its stock price of $3.95 by its TTM earnings per share of -$0.01.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Medexus Pharmaceuticals Inc.You MDP.TO | $128M | N/A | — | -$0.01 |
 BioNxt Solutions Inc. BNXT.CN | $53M | N/A | — | -$0.06 |
 The Cannabist Company Holdings Inc. CBST.NE | $17M | N/A | — | -$0.23 |
 Cardiol Therapeutics Inc. CRDL.TO | $172M | N/A | — | -$0.39 |
 C21 Investments Inc. CXXI.CN | $48M | N/A | — | -$0.03 |
 Decibel Cannabis Company Inc. DB.V | $66M | N/A | — | -$0.01 |
 iAnthus Capital Holdings, Inc. IAN.CN | $35M | N/A | — | -$0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | 27.81x | $0.09 | — | |
2024-03-31 FY2024 | — | $-0.01 | — | |
2023-03-31 FY2023 | 26.18x | $0.06 | — | |
2022-03-31 FY2022 | — | $-0.15 | — | |
2021-03-31 FY2021 | — | $-1.86 | — | |
2020-03-31 FY2020 | — | $-0.33 | — | |
2019-03-31 FY2019 | — | $-0.49 | — | |
2018-03-31 FY2018 | — | $-0.61 | — | |
2017-03-31 FY2017 | — | $-0.28 | — | |
2016-03-31 FY2016 | — | $-0.48 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Medexus Pharmaceuticals Inc. (MDP.TO) measures how much investors pay for each dollar of the company's trailing earnings. MDP.TO's current PE ratio of N/A is calculated by dividing its stock price of $3.95 by its TTM earnings per share of -$0.01.
Frequently asked questions
MDP.TO pe ratio · 6 questionsMDP.TO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.95 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via MDP.TO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Medexus Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08